lifesciences
Innopsys

Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms

Rheumatology Advance Access published online on December 23, 2009
Rheumatology, doi:10.1093/rheumatology/kep380.

Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms

 
Alejandro Balsa1, Jokin del Amo2, Francisco Blanco3, Rafael Caliz4, Lucía Silva5, Raimon Sanmarti6, Francisco G. Martínez7, Diego Tejedor2, Marta Artieda2, Dora Pascual-Salcedo8, Natividad Oreiro3, Maria D. Collado4, Jose L. Andreu5, Eduard Graell6, Laureano Simón2, Antonio Martínez2 and Juan Mulero5
 
  • 1Rheumatology Unit, Hospital Universitario La Paz, Madrid,
  • 2Research & Development, Progenika Biopharma, Bilbao,
  • 3Rheumatology Unit, Hospital Juan Canalejo, Coruña,
  • 4Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada,
  • 5Rheumatology Unit, Hospital Universitario Puerta de Hierro, Madrid,
  • 6Rheumatology Unit, Hospital Clínic, Barcelona,
  • 7Rheumatology Unit, Hospital Universitario Reina Sofía, Córdoba and
  • 8Immunology Unit, Hospital Universitario La Paz, Madrid, Spain.
     
Correspondence to: Alejandro Balsa, Rheumatology Unit, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046 Madrid, Spain. Email: abalsa.hulp@salud.madrid.org

Abstract

Objective. To develop a model to predict RA outcome based on biochemical variables and single nucleotide polymorphisms (SNPs).

HEAD OFFICE

Parc d'activités Activestre
31390 Carbonne - FRANCE

CONTACT

Phone +33 561 971 974
Fax +33 561 971 975